The Future of Clinical Trials Design: Lessons from COVID-19

12:00 PM - 12:45 PM (EDT), Tuesday, June 15, 2021
Search General Info
Search Education
Search Partnering Companies

How we conduct clinical trials has been evolving as a result of new technologies and tools – and the COVID-19 pandemic has driven the modernization of clinical trials by increasing use of decentralized trials, innovative methodologies, and digital technologies. Hear from regulators and drug developers on how best to use some of these new methods while still maintaining the high standards of safety, efficacy, and data integrity.

Sponsored By
Moderator
photo
Vice President, Data & Statistical Sciences
AbbVie
Speakers
photo
Vice President - Technical
Parexel International
photo
Vice President, Data & Statistical Sciences
AbbVie
photo
Chair of the Board, Senior Vice President, Global Head of Pharma Regulatory and Policy
Roche
photo
Acting Deputy Director, Office of New Drug Policy
US Food & Drug Administration